-+ 0.00%
-+ 0.00%
-+ 0.00%

EYEPOINT SHARES PLUNGE 82% TO $0.50 PREMARKET AFTER CO'S EYE DISEASE DRUG FAILS SECOND LATE-STAGE TRIAL

Reuters·10/19/2026 12:18:17

Please log in to view news